Previous work has shown increased formation of altered aspartate residues in membrane proteins during cell ageing and in response to oxidative stress in normal erythrocytes.. The increas
Trang 1Protein methylation as a marker of aspartate damage
in glucose-6-phosphate dehydrogenase-deficient erythrocytes
Role of oxidative stress
Diego Ingrosso1,2, Amelia Cimmino1, Stefania D’Angelo1, Fiorella Alfinito3, Vincenzo Zappia1,2
and Patrizia Galletti1,2
1 Department of Biochemistry and Biophysics, School of Medicine, Second University of Naples, Italy; 2 Cardiovascular Research Centre, School of Medicine, Second University of Naples, Italy;3Department of Hematology, School of Medicine,
University of Naples Federico II, Italy
The Mediterranean variant of glucose-6-phosphate
dehy-drogenase (G6PD) deficiency is due to the C563CT point
mutation, leading to replacement of Ser with Phe at position
188, resulting in acute haemolysis triggered by oxidants
Previous work has shown increased formation of altered
aspartate residues in membrane proteins during cell ageing
and in response to oxidative stress in normal erythrocytes
These abnormal residues are specifically recognized by
the repair enzyme L-isoaspartate (D-aspartate) protein
O-methyltransferase (PCMT; EC 2.1.1.77)
The aim of this work was to study the possible
involve-ment of protein aspartate damage in the mechanism linking
the G6PD defect and erythrocyte injury, through oxidative
stress Patients affected by G6PD deficiency (Mediterranean
variant) were selected In situ methylation assays were
per-formed by incubating intact erythrocytes in the presence of
methyl-labelled methionine Altered aspartate residues were
detected in membrane proteins by methyl ester
quantifica-tion
We present here evidence that, in G6PD-deficient ery-throcytes, damaged residues are significantly increased in membrane proteins, in parallel with the decay of pyruvate kinase activity, used as a cell age marker Erythrocytes from patients were subjected to oxidative stress in vitro, by treat-ment with t-butylhydroperoxide, monitored by a rise in concentration of both methaemoglobin and thiobarbituric acid-reactive substances.L-Isoaspartate residues increased dramatically in G6PD-deficient erythrocytes in response to such treatment, compared with baseline conditions The increased susceptibility of G6PD-deficient erythro-cytes to membrane protein aspartate damage in response
to oxidative stress suggests the involvement of protein deamidation/isomerization in the mechanisms of cell injury and haemolysis
Keywords: erythrocyte membrane; glucose-6-phosphate (G6PD) deficiency;L-isoaspartate residues; oxidative stress; protein methylation
Several biochemical variants of glucose-6-phosphate
dehy-drogenase (G6PD), corresponding to about 100 different
point mutations of the gene encoding this protein, have been
described [1] Many of these are associated with chronic or
acute haemolysis The Mediterranean clinical variant,
resulting from the C563CT change in the gene sequence,
results in the replacement of serine with phenylalanine at
position 188 Clinical outcome is characterized by neonatal
jaundice and acute haemolysis and haemoglobinuria
Haemolysis is triggered by exposure to oxidants, e.g fava
beans (the disease is often referred to as favism, and acute haemolysis is called favic crisis) or administration of drugs such as primaquine, nitrofurantoin, and sulfamethoxazole,
or infection [1] G6PD activity is almost undetectable in most patients [2,3] However, despite the vast amount of data on the characterization of different G6PD variants, the pathophysiological link between the enzyme defect and haemolysis has not been unequivocally elucidated Among G6PD-deficient erythrocytes, aged cells are the most sensitive to haemolysis, because of age-dependent decay of the activity of several enzymes, including G6PD, and antioxidant systems There is further evidence that altera-tions in the plasma membrane are central to the mechanism
of cell destruction [4,5] Under normal conditions, G6PD-deficient erythrocytes are removed, mainly by phagocytosis, upon opsonization by autologous immunoglobulins and complement [5] Haemolysis is in most cases autocompen-sated, as it appears to be limited to the oldest erythrocyte population [5] These observations indicate that biochemical alterations that occur naturally during erythrocyte ageing are part of the mechanism of haemolysis induced by oxidative stress in these patients
Spontaneous post-biosynthetic modifications of mem-brane proteins have been shown to occur during erythrocyte ageing, in particular deamidation of asparagine residues and
Correspondence to D Ingrosso, Department of Biochemistry and
Biophysics, Via Costantinopoli 16, 80138 Napoli, Italy.
Fax: + 39 081441688, Tel.: + 39 0815667522,
E-mail: diego.ingrosso@unina2.it
Abbreviations: G6PD, glucose-6-phosphate dehydrogenase; PCMT,
L -isoaspartyl-protein O-methyltransferase; PK, pyruvate kinase;
RFLP, restriction fragment length polymorphism; TBARS,
thio-barbituric acid-reactive substances; t-BHP, t-butylhydroperoxide;
AdoMet, S-adenosylmethionine; AdoHcy, S-adenosylcysteine.
Enzyme: L -isoaspartate ( D -aspartate) protein O-methyltransferase
(PCMT; EC 2.1.1.77).
(Received 24 October 2001, revised 8 February 2002, accepted 15
February 2002)
Trang 2isomerization of aspartate residues [6] Major targets of
these alterations, also called protein molecular fatigue
damage [7], are cytoskeletal components, such as ankyrin
and bands 4.1 and 4.2, as well as the integral membrane
protein band 3 (AE1; the anion transporter) [6] In this
respect, asparaginyl deamidation has been shown to play a
role in the shift of band 4.1b to 4.1a [8] during erythrocyte
ageing Increased molecular fatigue damage of several
cytoskeletal proteins has been found associated not only
with erythrocyte ageing, but also with intrinsic defects of
erythrocytes [7] In fact, L-isoaspartate, a major protein
fatigue degradation product, is increased in hereditary
spherocytosis, and its increase correlates positively with the
degree of spectrin deficiency [9] Erythrocyte passage
through the spleen microcirculation has also been found
to be a key determinant of this type of protein alteration in
spherocytosis [10] Therefore, deamidation and
isomeriza-tion of membrane proteins have been proposed to play a
role in spleen conditioning [10]
Major byproducts of protein fatigue at the Asn/Asp
(Asx) level areL-isoaspartate residues These residues are
selectively recognized by a specific S-adenosylmethionine
(AdoMet)-dependent enzyme,L-isoaspartate (D-aspartate)
protein O-methyltransferase (PCMT; EC 2.1.1.77) [11,12]
Enzymatic methylation of abnormal aspartate residues is
physiologically involved in the repair and/or disposal of
fatigue damaged proteins [13] Because of its unusual
substrate specificity, methylation can be used to monitor the
occurrence of these protein alterations as the erythrocyte
ages [7,8]
A number of erythrocyte stress conditions, including
oxidation, have been shown to significantly increase
isoas-partate content in normal erythrocyte membrane proteins,
detected by measuring methylation levels [14,15] The
rationale of this work was to detect the occurrence of such
alterations in G6PD deficiency and assess their extent in an
oxidative microenvironment Data presented here show that
the effect of oxidative stress on membrane protein
deam-idation/isomerization is significantly higher in
G6PD-defi-cient erythrocytes (Mediterranean variant) than normal
The implications of these findings in the pathophysiology of
haemolysis are discussed
M A T E R I A L S A N D M E T H O D S
Materials
S-Adenosyl[methyl-14C]methionine (58 mCiÆmmol)1) and
[methyl-3H]methionine (55 CiÆmmol)1) were from
Amer-sham International Ready Gel liquid-scintillation cocktail
was from Beckman Inc (Cuppertino, CA, USA) Percoll
was purchased from Pharmacia (Uppsala, Sweden)
Selec-tographin was obtained from Schering (Berlin, Bergkamen,
Germany) Thiobarbituric acid and t-butylhydroperoxide
(t-BHP) (70% aqueous solution) were from Sigma Co (St
Louis, MO, USA)
Patient enrolment and sample processing
All subjects to be enrolled were assessed by a standard
screening panel, evaluating blood G6PD activity and the
presence of the C563T point mutation A group of patients
and age/sex-matched normal controls were selected
Patients gave informed consent and were made aware of the outcomes of the study All procedures and manipula-tions, including blood sampling and genetic diagnostics, were subject to authorization by the patients Experimental design was subject to approval by the bioethics committee,
as required At the time of the study, patients were free of haemolysis and in good clinical condition Routine bio-chemical blood tests (Hitachi 911 Automatic Analyzer) and
a standard haematological screening test for anaemia were performed For all erythrocyte testing, blood samples were withdrawn in EDTA (1 mgÆmL)1 blood) and further processed for determination of G6PD activity [16] Control G6PD activity was 8.34 ± 1.59 UÆg)1 haemoglobin, as defined in the literature [16] Normal controls showed G6PD activity within this reference range, whereas patients had almost undetectable levels
When indicated, erythrocytes were separated according
to density as previously described [17] The two most abundant age-density fractions were used for the enzyme assays, and referred to as buoyant fraction and dense fraction Pyruvate kinase (PK) activity was measured, as a cell-age marker, in individual erythrocyte populations
Diagnostic evaluation and identification of the G6PD gene defect
The study investigated 15 unrelated, G6PD-deficient men The molecular defect was assessed as described previously [1] Briefly, lymphocytes from peripheral blood were isolated on
a Ficoll-Telepaque gradient; DNA was extracted [18], and G6PD exon 1 was amplified by PCR and isolated by agarose gel electrophoresis As shown in Fig 1, the C563T point mutation, responsible for the Mediterranean clinical variant, was then identified by digestion of PCR-amplified product with MboII [19] A complete haematological screening of these subjects revealed no other alteration For control purposes we also investigated 14 healthy men of the same age Erythrocyte oxidative treatment
Erythrocytes were subjected to oxidative stress as described previously [15], with modifications Cells, prepared as described above, were filtered through nylon net and thoroughly washed with phosphate buffered saline, spH 7.4, before the oxidative treatment This was per-formed by incubating the cells at 37Cin a shaking water bath, in the presence of t-BHP at the indicated concentra-tion, in 25-mL flasks (final haematocrit 10%) After incubation, supernatants were used to determine levels
of thiobarbituric acid-reactive substances (TBARS) as described below Erythrocytes were washed seven times with isotonic buffer to remove t-BHP
Evaluation of oxidation markers Determination of methaemoglobin and oxyhaemoglo-bin Methaemoglobin and oxyhaemoglobin contents were determined by a spectrophotometric method [20] Briefly,
5 lL packed oxidized erythrocytes were mixed with 995 lL stabilizing solution (2.7 mM EDTA, pH 7.0, and 0.7 mM 2-mercaptoethanol) After shaking, oxyhaemoglobin and methaemoglobin concentrations were measured spectro-photometrically
Trang 3Evaluation of lipid peroxidation Lipid peroxidation was
evaluated by detecting the amount of TBARS, mainly
malondialdehyde, as described previously [21] Briefly, 2 mL
of the supernatant of oxidized erythrocyte pellet was mixed
with 1 mL 30% (w/v) trichloroacetic acid and centrifuged at
5000 g for 15 min A 2-mL aliquot of supernatant was added
to 0.5 mL 1% (w/v) thiobarbituric acid in 0.05MNaOH and
heated in a boiling-water bath for 10 min The absorbance of
the developing pink chromophore was measured at 532 nm
Methyl esterification of membrane proteins in intact
erythrocytes (in situ assay)
Every day at least one patient and one control sample was
processed in parallel When oxidative stress was applied,
control and patient samples were treated at the same time
Intact erythrocytes were incubated with methyl-labelled
methionine, the in vivo precursor of AdoMet [6] First,
250 lL packed erythrocytes were resuspended in an equal
volume of 5 mM Tris/HCl buffer (pH 7.4), containing
160 mMNaCl, 0.96 mMMgCl2, and 2.8 mMglucose Then
0.93 nmolL-[methyl-3H]methionine (15 lCi) was added and
the mixture incubated at 37Cfor 60 min Cells were then
haemolysed in hypotonic buffer (5 mMsodium phosphate,
pH 8.0, containing 25 mMphenylmethanesulfonyl fluoride)
Membranes were then washed twice with the same hypotonic
solution at decreasing pH (7.2 and 6.2) to preserve methyl
ester stability Radioactivity incorporated as protein methyl
esters was determined after solubilization of 10 lL membrane
preparation in 125 lL 10 mMacetic acid/2.5% SDS Protein
concentration was determined as described previously [6]
Electrophoretic analysis of membrane proteins
SDS/PAGE of membrane erythrocytes was performed by
method of Fairbanks et al.[22] with modifications [9] The
gels were 1.5 mm thick and contained acrylamide mix 5.6% (mass/vol), in the presence of 1% SDS, at pH 7.4 All samples were run in duplicate so that one control and one treated (and/or patient) samples were analysed in parallel on each gel half of the same gel At the end of the run, gels were cut into half, and one half was stained with Coomassie Brilliant Blue to visualize protein bands and densitometri-cally scanned for area quantification [9] The other half was used for methyl ester quantification For this, lanes were sliced into 2-mm fractions and the incorporated radioacti-vity was determined after elution of proteins from each slice [6,9] Radioactivity was expressed as d.p.m./band area
Determination of AdoMet andS-adenosylhomocysteine intracellular content
Intracellular concentrations of AdoMet and S-adenosyl-homocysteine were determined by HPLCin a perchloric acid-soluble fraction of erythrocyte cytosol [23] All samples were filtered through a 0.2-lm pore filter before injection on
to a Zorbax C8 reverse-phase column (25 cm· 4 mm; Du Pont-New England Nuclear, Boston, MA, USA), equili-brated with buffer A (50 mMNaH2PO4/10 mM heptanesulf-onic acid buffer, pH 3.2), containing 4% (w/v) acetonitrile Nucleosides were eluted with a 15-min linear gradient of 4–20% acetonitrile, followed by a 10-min linear gradient of 20–25% acetonitrile, at a flow rate of 1 mLÆmin)1
Enzyme assays PCMT specific activity was determined, in vitro, in the cytosol of erythrocytes subjected to oxidative stress, as previously described [9,24] Erythrocyte lysates were obtained by rapid freeze–thawing after 10-fold dilution of oxidized erythrocytes with a stabilizing solution (2.7 mM EDTA, pH 7.0, and 0.7 m 2-mercaptoethanol) [16]
Wild type
Mediterranean
120 100 317
417
1 2 3 4 5 6 7 8 9 10 11 St
317
120 100
Fig 1 Diagnostic assessment of molecular defect in G6P-deficient patients Patient selection, sampling and DNA extraction were as described in Materials and Methods The C563T mutation, associated with the Mediterranean variant was identified after PCR amplification of exon 5 and 6, followed by digestion with MboII restriction enzyme (A) Schematic representation of the expected restriction fragment length polymorphism (RFLP) in wild-type and Mediterranean mutants, where the latter show an additional MboII site (B) RFLP analysis of some patients and controls.
1, 3, 10, Mediterranean variant male patients; 4, 5, heterozygous females; 2, 7, 9, 11, normal controls Mutants are characterized by sensitivity to MboII digestion of PCR amplified fragments, yielding additional bands of 317 and 100 bp, respectively.
Trang 4Membranes were removed by centrifugation at 10 000 g for
20 min The assay mixture contained, in a final volume of
40 lL, 1.6 mg ovalbumin as the methyl acceptor, 2.8 mg
cytosolic proteins, 0.1Msodium citrate buffer, pH 6.0, and
30 lM (final concentration) S-adenosyl-L-[methyl-14
C]-methionine as the methyl donor After incubation at
37Cfor 10 min, the reaction was quenched by adding
an equal volume (40 lL) of 0.2MNaOH/1% (w/v) SDS
Radioactivity due to methyl incorporation was determined
as previously described [9] Results are expressed as enzyme
units (pmol methyl ester formedÆmin)1) per mg
haemoglo-bin Haemoglobin concentration was determined
spectro-photometrically [24]
PK activity was evaluated as a cell-age marker by the
method of Beutler et al [16]
Statistical analysis
Statistical analysis was performed by Student’s paired or
unpaired t-test Results are presented as the mean ± SE
Differences were considered significant at P < 0.05
R E S U L T S A N D D I S C U S S I O N
Methyl esterification of membrane proteins
is increased particularly in the G6PD-deficient
‘dense’ erythrocyte fraction
There is evidence from at least three independent
labora-tories that methyl esterification of membrane proteins,
catalysed by PCMT, is increased as erythrocytes age in the
circulation [6,25,26] This has been related to an increased
number of abnormal aspartate residues, spontaneously
arising fromL-asparaginyl deamidation and/orL-aspartyl
isomerization reactions [7] In addition it has been reported
that isoaspartate residues, detected by the PCMT in situ
assay, increase in membrane proteins of normal
erythro-cytes subjected to oxidative stress [14], suggesting that
susceptibility to oxidative damage may render these
mem-brane protein components more prone to deamidation/
isomerization
We measured methyl esterification of membrane proteins
in G6PD-deficient erythrocytes, to establish if abnormal
isoaspartate residues occur, in this condition, at a higher
rate than normal, while in the circulation To this end, cells
were fractionated according to density, the two most
abundant, intermediate fractions being used in the
subse-quent procedure Cell recovery in these fractions, with
respect to the total amount of cells loaded on to the
gradient, was 70.3 ± 5.1% (control) vs 80.9 ± 3.8%
(G6PD) Cell percentages were 46.6 ± 4.1% (buoyant
fraction) vs 23.7 ± 1.9 (dense fraction) for the control
samples, and 61.0 ± 3.2% (buoyant fraction) vs
19.9 ± 2.3 (dense fraction) for the G6PD samples An
equal number of cells from each fraction was incubated with
methyl-labelled methionine, the in vivo AdoMet precursor
PK activity was measured in parallel, as a cell age marker, in
cytosolic extracts of the same erythrocyte fractions PK
activities in the dense cell fraction, in both normal and
G6PD-deficient cells, were always significantly lower than in
the corresponding buoyant cell fraction (Fig 2A),
confirm-ing that PK is a suitable cell age marker in the
G6PD-deficient as well the normal erythrocyte Moreover PK
activity in the G6PD-deficient erythrocytes was significantly higher than in the corresponding control cell populations (Fig 2A) This is consistent with G6PD-deficient erythro-cytes having a reduced half-life in the circulation
Each cell fraction from individual patient populations was then subjected to the in situ methylation assay A general increase in methyl ester formation with cell age was found in membrane proteins of both pathological and normal erythrocytes However, this age-dependent increase
in methylation (i.e protein damage) was significantly more marked in the membrane of G6PD-deficient erythrocytes than controls (Fig 2B), despite the fact that the control cells were older (i.e their life span was prolonged) according to
PK activity
As a whole, the results show that, in G6PD deficiency, erythrocyte membrane proteins have an increased tendency
to isoaspartate formation, in spite of the reduced half-life of the circulating erythrocyte population In other words, the increase in altered residues resulting from protein deamida-tion/isomerization reactions show a premature onset with erythrocyte ageing, in the G6PD deficiency Mediterranean variant
Oxidative stress increases membrane protein ‘fatigue’ damage in G6PD-deficient erythrocytes
It has been reported that oxidation, induced by cell treatment with t-BHP, leads to significant membrane alterations, including the occurrence of deamidated/isomer-ized Asx residues of membrane-cytoskeletal proteins [15]
Fig 2 Membrane protein methylation levels and PK activity of density-fractionated G6PD-deficient erythrocytes (A) PK activity, as a cell-age marker, was determined in erythrocyte cytosol, as detailed in Materials and methods (B) Membrane protein methylation levels were deter-mined in two different erythrocyte age/density fractions obtained by isopycnic centrifugation on a Percoll gradient Methyl esterification in intact erythrocytes was assayed by incubating them in the presence of [ 3 H]methionine according to the in situ procedure (see Materials and methods).
Trang 5We were therefore intrigued to investigate whether the
abnormal susceptibility of G6PD-deficient erythrocytes to
oxidative stress could be responsible for their increased
tendency to isoaspartate formation in membrane proteins
Therefore we monitored development of this alteration to
evaluate its pathophysiological meaning in the mechanism
of cell damage, using the in situ methylation assay, in
isolated G6PD-deficient erythrocytes subjected to oxidative
stress
Erythrocytes from both normal control and
G6PD-deficient patients were subjected to oxidant treatment, with
t-BHP, before the in situ methylation assay To limit
possible interference of cell manipulation with the oxidative
stress conditions, cells were not fractionated according to
density The effects of reactive oxygen species on erythrocyte
membranes were assessed by measuring lipid peroxidation
products (Fig 3A), which showed a dramatic rise Proteins
were also generally affected by the oxidative treatment, as
demonstrated by the increase in methaemoglobin
concen-tration (Fig 3B) As expected, the effects of the oxidant
treatment were much more dramatic on G6PD-deficient
erythrocytes than on normal cells
We next evaluated the effects of such treatment on
isoaspartate formation, by measuring the levels of
mem-brane protein methyl esters by the in situ methylation assay
PK activity was also measured in parallel, to assess the loss
of the older cell fractions as the result of possible
haemol-ysis Figure 4A shows that erythrocyte exposure to
oxida-tive conditions resulted in higher intracellular PK activity,
probably due to haemolysis, which affected the oldest,
intrinsically less resistant cells, so that the remaining
erythrocyte population was significantly younger This
effect was clearly more pronounced in G6PD-deficient than
normal erythrocytes
Methyl esterification of membrane proteins was mea-sured in parallel, in order to monitor isoaspartate forma-tion Figure 4B shows that such abnormal residues increased in membrane proteins in response to oxidants in both normal and pathological erythrocytes, but to different extents This effect was in fact significantly more marked in G6PD deficiency, particularly when we consider that, in this disease, the erythrocyte population that survived the in vitro oxidative stress was younger than the controls (compare Figs 4A and 4B) No significant differences were noted in the AdoMet and AdoHcy concentrations, as well as in PCMT specific activity, after oxidative treatment, confirm-ing our previous findconfirm-ings [15]
As a whole, the results indicate that the lack of reducing power is a crucial element in conditioning erythrocyte susceptibility to undergo membrane protein damage in the form of Asx deamidation/isomerization Isoaspartate formation may also be one of the ultimate events in cell destruction Evidence shows that erythrocyte removal during cell ageing or after oxidative damage is mediated by binding of band 3 antibodies to band 3 antigenic sites [5] Therefore, the occurrence of altered aspartate residues in band 3 of normal and abnormal erythrocytes during ageing [6,7] or oxidative stress [15] may be relevant to the fact that the same protein becomes
a major site of new antigen generation under the same conditions
It should be pointed out, in this respect, that erythrocyte ageing was initially believed to be the main determinant of isoaspartate formation in membrane proteins [6] Our results are in line with a different interpretation, which underscores the equally important role played by cell stress
in the occurrence of such protein damage This may be particularly relevant to pathological conditions, such as
Fig 3 Evaluation of oxidation markers in G6PD-deficient erythrocytes
subjected to oxidative stress Measurements were performed on both
G6PD-deficient and normal control erythrocytes after exposure to
oxidative stress with t-BHP (A) TBARS evaluation of incubation
medium; (B) methaemoglobin content in erythrocyte cytosol.
Fig 4 Membrane protein methylation levels and PK activity of G6PD-deficient erythrocytes subjected to oxidative stress (A) PK activity, as a cell age marker, was measured in parallel in the cytosolic fraction of the same cell preparations (B) Membrane protein methylation levels were evaluated by the in situ methylation assay.
Trang 6spherocytosis or G6PD deficiency, in which erythrocytes are
intrinsically altered, so that they are more prone to this type
of protein alteration than normal
Protein methyl esterification as an adaptive response
to cell exposure to damaging conditions
Different spontaneous post-biosynthetic modifications have
been shown to occur during erythrocyte senescence For
example nonenzymatic glycosylation of haemoglobin (gly-cation) has been shown to increase in the course of mismanaged hyperglycaemia in diabetes [27] Haemoglobin
is a useful protein marker of this kind of damage, although a number of other protein molecules are known to be affected
by this alteration, with unpredictable functional conse-quences
Deamidation/isomerization of Asx residues has been shown to occur in haemoglobin a chain [28] Haemoglobin mutations have been also shown to increase its susceptibility
to deamidation, such as in the case of haemoglobin
Providence [29] Nevertheless the major targets of Asx deamidation/isomerization during cell ageing are several constituents of the membrane-cytoskeletal network The electrophoretic shift of protein 4.1 has been shown to occur
in aged erythrocytes, and it is due to deamidation of sensitive asparagine residues [8] This protein is involved in the maintenance of erythrocyte shape and deformability, by stabilizing interactions between the spectrin–actin network and integral membrane proteins glycophorin Cand band 3 (AE1) [30]
The functional consequences of deamidation/isomeriza-tion have often been investigated under near-pathological conditions Homozygous knockout mice for PCMT are affected by growth retardation, and die prematurely with tonic-clonic seizures [31,32] In these animals, isomerized proteins accumulate in all organs and tissues, indicating lack
of PCMT-driven repair activity [31,32] However, the functional outcome of such alterations on individual proteins is still uncertain, although the biological activity
of different proteins appears to be compromised in vitro by deamidation and isomerization Previous experience with several cell models has shown that the isoaspartate content
of intracellular proteins is increased as the result of heat shock [33] as well as of UVA irradiation [34] As far as the
Fig 5 SDS/PAGE profile of membrane proteins from G6PD-deficient
and normal erythrocytes subjected to oxidative stress Oxidative stress
was induced, where indicated, by t-BHP treatment Lane 1,
nonoxi-dized normal erythrocyte; lane 2, oxinonoxi-dized normal erythrocyte; lane 3,
nonoxidized deficient erythrocyte; lane 4, oxidized
G6PD-deficient erythrocyte.
Fig 6 Schematic representation of the overall hypothesis on the relationships between oxidative stress and isoaspartate formation in G6PD deficiency G6PD-deficient erythrocytes are intrinsically less resistant to subliminal oxidant levels, so that protein deamidation/isomerization products (i.e isoaspartate residues) tend to accumulate despite the fact that the life span of these cells is, on average, shorter than normal In other words, they reach levels of aspartate damage that are typical of a much older normal erythrocyte population Exposure to certain foods or drugs (fava beans, nonsteroidal anti-inflammatory drugs, antimalaria drugs, chemotherapeutics, etc.) trigger the haemolytic crisis, which is also associated with a further increase in the levels of deamidated/isomerized proteins The mechanism linking oxidation to haemolysis involves membrane alterations.
Trang 7erythrocyte is concerned, there is evidence that
deamida-tion/isomerization of Asx residues, monitored by
methyla-tion, is significantly increased under cell stress conditions
This occurs when erythrocytes are subjected to
haemody-namic shear forces in a metabolically hostile
microenviron-ment, such as the spleen microcirculation [35] These results
support the role of protein fatigue damage in the mechanism
of spleen conditioning, in haemocatheresis [35,36] It has
also been shown that membrane–cytoskeletal proteins of
resealed/engineered erythrocytes display increased
suscepti-bility to molecular fatigue, detected by methyl
esterifica-tion, after repeated osmotic stress [14]
In a previous report on the effects of oxidative stress on
normal erythrocytes, we found that treatment with t-BHP
increased isoaspartate occurrence in membrane proteins
[15] Conversely, we did not observe under such conditions
any of the extensive membrane alterations described by
others, including formation of protein aggregates with
haemoglobin [15]
The electrophoretic pattern of membrane proteins from
G6PD-deficient cells, both treated and untreated with
oxidants, was similar to that of controls (Fig 5) This
allows us to conclude that molecular alterations, in the form
of isoaspartate residues, take place on t-BHP treatment,
before and not as a consequence of massive alterations of
membrane protein composition The results indicate that
protein damage at the aspartate level is a sensitive and early
marker of erythrocyte exposure to oxidants, before the
appearance of more extensive damage of morphological
relevance [15]
In conclusion, the data presented here show that G6PD
deficiency, which renders erythrocyte adaptation to an
oxidative microenvironment more difficult, makes
mem-brane proteins more prone to isoaspartate formation, both
during cell ageing and, even more so, under stress conditions
(see scheme in Fig 6) Taken as a whole, the results support
the role of this post-biosynthetic protein modification in the
mechanism of haemolysis in G6PD deficiency
A C K N O W L E D G E M E N T S
Genetic testing of patients was accomplished at the International
Institute of Genetic and Biophysics (I.I.G.B.) of the National Research
Council, Naples, Italy, under the supervision of Dr Giuseppe Martini
and Stefania Filosa The work was supported in part by research grants
from Ministero dell’Istruzione, dell’Universita` e della Ricerca, Progetti
di Rilevante Interesse Nazionale (M.I.U.R P.R.I.N., 1999): Extra and
intracellular nucleotide and nucleoside: chemical signals, metabolic
regulators and potential drugs and Hyperhomocysteinemia as a
cardiovascular risk factor: biochemical mechanism(s).
R E F E R E N C E S
1 Luzzatto, L., Mehta, A & Vulliamy, T (2001) Glucose
6-phos-phate dehydrogenase deficiency In The Metabolic and Molecular
Bases of Inherited Disease (Scriver, C R., Beaudet, A.L., Sly, W.S.
& Valle, D., eds), vol 3, pp 4517–4553 McGraw-Hill, New York.
2 Mason, J.P (1996) New insights into G6PD deficiency Br.
J Haematol 94, 585–591.
3 Beutler, E., Vulliamy, T & Luzzatto, L (1996) Hematological
important mutation: glucose-6-phosphate dehydrogenase Blood
Cell Mol Dis 22, 49–56.
4 Pandolfi, P.P., Sonati, F., Rivi, R., Mason, P., Grosveld, F &
Luzzatto, L (1995) Target disruption of the housekeeping gene
encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for defense against oxidative stress EMBO J 14, 5209–5215.
5 Arese, P & De Flora, A (1990) Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency Semin Hematol.
27, 1–40.
6 Galletti, P., Ingrosso, D., Nappi, A., Gragnaniello, V., Iolascon,
A & Pinto, L (1983) Increased methyl esterification of membrane proteins in aged red-blood cells Preferential esterification of ankyrin and band 4.1 cytoskeletal proteins Eur J Biochem 13, 25–31.
7 Galletti, P., Ingrosso, D., Manna, C., Clemente, G & Zappia, V (1995) Protein damage and methylation-mediated repair in the erythrocyte Biochem J 306, 313–325.
8 Inaba, M., Gupta, K.C., Kuwabara, M., Takahashi, T., Benz, E.J.
Jr & Maede, Y (1992) Deamidation of human erythrocyte protein 4.1: possible role in ageing Blood 79, 3355–3361.
9 Ingrosso, D., D’Angelo, S., Perna, A.F., Iolascon, A., Miraglia del Giudice, E., Perrotta, S., Zappia, V & Galletti, P (1995) Increased membrane-protein methylation in hereditary spherocytosis A marker of cytoskeletal disarray Eur J Biochem 228, 894–898.
10 Ingrosso, D., D’Angelo, S., Perrotta, S., D’Urzo, G., Iolascon, A., Perna, A.F., Galletti, P., Zappia, V & Miraglia del Giudice, E (1996) Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: evidence for a differentiated splenic con-ditioning role Br J Haematol 93, 38–41.
11 Johnson, B.A., Langmack, E.L & Aswad, D.W (1987) Partial repair of deamidation-damaged calmodulin by protein carboxyl methyltransferase J Biol Chem 262, 12283–12287.
12 Ryttersgaard, C., Griffith, S.C., Sawaya M.R., MacLaren D.C., Clarke, S & Yeates, T.O (2002) Crystal structure of human
L -isoaspartyl methyltransferase J Biol Chem., Manuscript M200229200.
13 Ota, I.M & Clarke, S (1990) The function and enzymology of protein D -aspartyl/ L -isoaspartyl methyltransferase in eukaryotic and prokaryotic cells In Protein Methylation (Paik, W.K & Kim, S., eds), pp 179–194 CRC Press, Boca Raton, FL.
14 Ingrosso, D., Cotticelli, M.G., D’Angelo, S., Buro, M.D., Zappia,
V & Galletti, P (1997) Influence of osmotic stress on protein methylation in reasealed erythrocytes Eur J Biochem 244, 918– 922.
15 Ingrosso, D., D’Angelo, S., di Carlo, E., Perna, A.F., Zappia, V & Galletti, P (2000) Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress Eur J Biochem 267, 4397–4405.
16 Beutler, E., Blume, K.G., Lohr, G.W., Ramot, B & Valentine, W.N (1977) International committee for standardization in hae-matology: recommended methods for red-cell enzyme analysis.
Br J Haematol 35, 331–341.
17 Vettore, L., De Matteis, M.C & Zampini, P (1980) A new density gradient system for the separation of human red blood cells.
Am J Hematol 8, 291–297.
18 Sykes, B.C (1983) DNA in heritable disease Lancet 2, 787–788.
19 Alfinito, F., Cimmino, A., Ferraro, F., Cubellis, M.V., Vitagliano, L., Francese, M., Zagari, A., Rotoli, B., Filosa, F & Martini, G (1997) Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity, correlation genotype-phenotype and descrip-tion of a new variant (G6PD Neapolis) Br J Haematol 98, 41–46.
20 Winterbourn, C.C (1990) Oxidative reactions of hemoglobin Methods Enzymol 186, 265–272.
21 Caprari, P., Bozzi, A., Malorni, W., Bottini, A., Iosi, F., Santini, M.T & Salvati, A.M (1995) Junctional sites of erythrocyte ske-letal proteins are specific targets of tert-butylhydroperoxide oxi-dative damage Chem-Biol Interact 94, 243–258.
22 Fairbanks, G., Steck, T.L & Wallach, D.F.H (1971) Electro-phoretic analysis of the major polypeptides of the human ery-throcyte membrane Biochemistry 10, 2606–2616.
Trang 823 Cools, M., Hasobe, M., De Clerq, E & Borchardt, R.T (1990)
Mechanism of the synergistic antiviral and cytostatic activity of
(RS)-3-(adenin-9-yl)-2-hydroxypropanoic acid isobutyl ester and
D , L -homocysteine Biochem Pharmacol 39, 195–202.
24 Gilbert, J.M., Fowler, A.V., Bleibaum, J & Clarke, S (1988)
Purification of homologous protein carboxyl methyltransferase
isozymes from human and bovine erythrocytes Biochemistry 27,
5227–5233.
25 Barber, J.R & Clarke, S (1983) Membrane protein carboxyl
methylation increases with human erythrocyte age J Biol Chem.
258, 1189–1196.
26 O’Connor, M.C & Yutzey, K.E (1998) Enhanced carboxyl
methylation of membrane-associated hemoglobin in human
ery-throcytes J Biol Chem 263, 1386–1130.
27 Vlassara, H (1990) Advanced non-enzymatic tissue glycosylation:
mechanism implicated in the complications associated with aging.
In Molecular Biology of Aging (Finch, C.E & Johnson, T.E., eds),
pp 171–185 Wiley-Liss, New York.
28 Ladino, C.A & O’Connor, C.M (1991) Identification of a site for
carboxyl methylation in human a-globin Biochem Biophys Res.
Commun 180, 742–747.
29 Bonaventura, J., Bonaventura, C., Sullivan, B., Ferruzzi, G.,
McCurdy, P.R., Fox, J & Moo-Penn, W.F (1976) Hemoglobin
providence Functional consequences of two alterations of the
2,3,diphosphoglycerate binding site at position b82 J Biol Chem.
251, 7563–7571.
30 Cohen, C.M & Gastard, P (1992) Regulation and post-trasnla-tional modofocation of erythrocyte membrane protein and membrane skeletal proteins Semin Hematol 29, 244–292.
31 Kim, E., Lowenson, J.D., MacLaren, D.C., Clarke, S & Young, S.G (1997) Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice Proc Natl Acad Sci USA 94, 6132–6137.
32 Kim, E., Lowenson, J., Clarke, S & Young, S.G (1999) Pheno-typic analysis of seizure-prone mice lacking L -isoaspartate ( D -aspartate) O-methyltransferase J Biol Chem 274, 20671– 20678.
33 Ladino, C.A & O’Connor, C.M (1992) Methylation of atypical protein aspartyl residues during the stress response of the HeLa cells J Cell Physiol 153, 297–304.
34 D’Angelo, S., Ingrosso, D., Perfetto, B., Baroni, A., Zappia, M., Lobianco Lubrano, L., Tufano, M.A & Galletti, P (2001) UVA-irradiation induces L -isoaspartyl formation in melanoma cell proteins Free Radic Biol Med 31, 1–9.
35 Gallagher, P.G., Forget, B.G & Lux, S.E (1998) Disorders of the erythrocyte membrane In Hematology of Infancy and Childhood (Nathan D.G & Oski, F.A., eds), pp 544–664 Saunders, Phila-delphia.
36 Bartosz, G (1990) Erythrocyte membrane changes during ageing
in vivo In Blood Cell Biochemistry (Harris, J.R., ed.), pp 45–81 Kluwer Academic/Plenum Publishers, New York.